1.
Lupus
; 24(3): 339-40, 2015 Mar.
Article
in English
| MEDLINE
| ID: mdl-25378239
2.
Rev. clín. esp. (Ed. impr.)
; 213(4): 219-219, mayo 2013.
Article
in Spanish
| IBECS
| ID: ibc-112529
Subject(s)
Humans , Female , Adult , Pseudotumor Cerebri/complications , Pseudotumor Cerebri/diagnosis , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Acetazolamide/therapeutic use , Pseudotumor Cerebri/epidemiology , Pseudotumor Cerebri/physiopathology , Pseudotumor Cerebri , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/physiopathology , Tomography, Optical Coherence/methods , Immunosuppressive Agents/therapeutic use , Cyclophosphamide/therapeutic use
3.
Rev. clín. esp. (Ed. impr.)
; 212(10): e87-e87, nov. 2012. ilus
Article
in Spanish
| IBECS
| ID: ibc-107488
Subject(s)
Humans , Male , Middle Aged , Arthritis, Psoriatic/complications , Arthritis, Psoriatic/diagnosis , Arthritis, Psoriatic/drug therapy , Onycholysis/complications , Onycholysis/diagnosis , Hyperkeratosis, Epidermolytic/complications , Keratoderma, Palmoplantar/complications , Arthritis, Psoriatic/physiopathology , Arthritis, Psoriatic , Psoriasis/complications , Finger Joint/pathology , Finger Joint , Toe Joint/pathology , Toe Joint , Amputation, Surgical/methods , Foot Deformities/pathology , Foot Deformities
4.
Rev Clin Esp
; 212(10): e87, 2012 Nov.
Article
in Spanish
| MEDLINE
| ID: mdl-22867959
5.
Rev. esp. patol. torac
; 23(4): 311-314, oct.-dic. 2011. ilus, tab
Article
in Spanish
| IBECS
| ID: ibc-104708
Subject(s)
Humans , Male , Female , Adult , Aged , Thymus Neoplasms/pathology , Mediastinal Neoplasms/pathology , Neoplasm Metastasis/pathology , Neoplasms/classification
6.
Lupus
; 20(12): 1321-3, 2011 Oct.
Article
in English
| MEDLINE
| ID: mdl-21719526
ABSTRACT
We present a case of a man diagnosed with systemic lupus erythematosus, associated antiphospholipid syndrome and Evans syndrome, who developed a severe thrombocytopenia refractory to treatment with first-line drugs, cyclophosphamide and rituximab, and who responded to romiplostim with a normalization of the platelet recount, which later enabled a therapeutic splenectomy to be performed.